CHAMPION-AF Clinical Trial (CHAMPION-AF)
Diseases of the Cardiovascular System
What is the purpose of this trial?
The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.
- Ages18 years and older
- Trial withBoston Scientific Corporation
- Start Date07/01/2021
- End Date12/31/2025
- Last Updated11/04/2021
- Study HIC#2000028952